Table 1.
Reference | Risk of bias |
Concerns regarding applicability |
|||||
---|---|---|---|---|---|---|---|
Patient selection | Index test | Reference standard | Flow and timing | Patient selection | Index test | Reference standard | |
Gastro-oesophageal cancer | |||||||
Abela et al.40 | + | – | – | – | + | – | + |
Amal et al.32 | + | + | + | + | + | + | + |
Amal et al.31 | + | – | + | ? | + | + | + |
Chen et al.33 | + | – | + | ? | + | + | + |
Daniel and Thangavel34 | + | ? | + | + | + | ? | + |
Duran-Acevedo et al.35 | ? | – | + | ? | + | + | + |
Kumar et al.42 | – | – | + | + | + | + | + |
Kumar et al.41 | + | + | + | + | + | + | + |
Markar et al.43 | – | + | + | + | + | + | + |
Schuermans et al.36 | + | + | + | – | + | + | + |
Shehada et al.37 | ? | + | ? | ? | + | + | ? |
Tong et al.38 | ? | ? | ? | ? | + | – | ? |
Xu et al.39 | – | + | + | ? | + | + | + |
Zou et al.44 | ? | – | ? | ? | + | + | ? |
Colorectal cancer | |||||||
Altomare et al.49 | + | + | + | ? | + | + | + |
Altomare et al.48 | – | – | + | – | – | + | ? |
Amal et al.50 | + | + | + | + | + | + | + |
Peng et al.51 | – | – | ? | – | + | – | + |
van de goor et al.52 | + | + | + | ? | – | + | + |
Wang et al.53 | – | – | + | + | + | + | + |
Liver cancer | |||||||
Qin et al.45 | ? | – | + | – | ? | + | + |
Pancreatic cancer | |||||||
Markar et al.46 | + | + | + | + | + | + | + |
Princivalle et al.47 | ? | – | ? | – | + | + | + |
+, Low risk; –, high risk; ?, unclear risk.